Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204).
Churchyard GJ, Morgan C, Adams E, Hural J, Graham BS, Moodie Z, Grove D, Gray G, Bekker LG, McElrath MJ, Tomaras GD, Goepfert P, Kalams S, Baden LR, Lally M, Dolin R, Blattner W, Kalichman A, Figueroa JP, Pape J, Schechter M, Defawe O, De Rosa SC, Montefiori DC, Nabel GJ, Corey L, Keefer MC; NIAID HIV Vaccine Trials Network. Churchyard GJ, et al. Among authors: kalichman a. PLoS One. 2011;6(8):e21225. doi: 10.1371/journal.pone.0021225. Epub 2011 Aug 3. PLoS One. 2011. PMID: 21857901 Free PMC article. Clinical Trial.
A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects.
Keefer MC, Frey SE, Elizaga M, Metch B, De Rosa SC, Barroso PF, Tomaras G, Cardinali M, Goepfert P, Kalichman A, Philippon V, McElrath MJ, Jin X, Ferrari G, Defawe OD, Mazzara GP, Montefiori D, Pensiero M, Panicali DL, Corey L; NIAID HIV Vaccine Trials Network. Keefer MC, et al. Among authors: kalichman a. Vaccine. 2011 Feb 24;29(10):1948-58. doi: 10.1016/j.vaccine.2010.12.104. Epub 2011 Jan 7. Vaccine. 2011. PMID: 21216311 Free PMC article. Clinical Trial.
Safety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adults.
Kalams SA, Parker S, Jin X, Elizaga M, Metch B, Wang M, Hural J, Lubeck M, Eldridge J, Cardinali M, Blattner WA, Sobieszczyk M, Suriyanon V, Kalichman A, Weiner DB, Baden LR; NIAID HIV Vaccine Trials Network. Kalams SA, et al. Among authors: kalichman a. PLoS One. 2012;7(1):e29231. doi: 10.1371/journal.pone.0029231. Epub 2012 Jan 5. PLoS One. 2012. PMID: 22242162 Free PMC article. Clinical Trial.
Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step Study).
Duerr A, Huang Y, Buchbinder S, Coombs RW, Sanchez J, del Rio C, Casapia M, Santiago S, Gilbert P, Corey L, Robertson MN; Step/HVTN 504 Study Team. Duerr A, et al. J Infect Dis. 2012 Jul 15;206(2):258-66. doi: 10.1093/infdis/jis342. Epub 2012 May 4. J Infect Dis. 2012. PMID: 22561365 Free PMC article. Clinical Trial.
The HIV-Brazil cohort study: design, methods and participant characteristics.
Grangeiro A, Escuder MM, Cassenote AJ, Souza RA, Kalichman AO, Veloso VG, Ikeda ML, Barcellos NT, Brites C, Tupinanbás U, Lucena NO, da Silva CL, Lacerda HR, Grinsztejn B, Castilho EA. Grangeiro A, et al. Among authors: kalichman ao. PLoS One. 2014 May 1;9(5):e95673. doi: 10.1371/journal.pone.0095673. eCollection 2014. PLoS One. 2014. PMID: 24789106 Free PMC article.
Implementation of "Treat-all" at adult HIV care and treatment sites in the Global IeDEA Consortium: results from the Site Assessment Survey.
Brazier E, Maruri F, Duda SN, Tymejczyk O, Wester CW, Somi G, Ross J, Freeman A, Cornell M, Poda A, Musick BS, Zhang F, Althoff KN, Mugglin C, Kimmel AD, Yotebieng M, Nash D; IeDEA Consortium. Brazier E, et al. J Int AIDS Soc. 2019 Jul;22(7):e25331. doi: 10.1002/jia2.25331. J Int AIDS Soc. 2019. PMID: 31623428 Free PMC article.
COVID-19 and HIV/AIDS in a cohort study in Sao Paulo, Brazil: outcomes and disparities by race and schooling.
Rocha SQ, Avelino-Silva VI, Tancredi MV, Jamal LF, Ferreira PRA, Tayra A, Ferreira PM, Carvalhanas T, Domingues CSB, Souza RA, Gianna MC, Kalichman AO, Leite OHM, Souza TNL, Gomes E Costa DA, Furtado JJD, Costa AF; HIV-COVID/SP Study Group. Rocha SQ, et al. Among authors: kalichman ao. AIDS Care. 2022 Jul;34(7):832-838. doi: 10.1080/09540121.2021.1936444. Epub 2021 Jun 4. AIDS Care. 2022. PMID: 34082616
Randomized, double-blind trial comparing indinavir alone, zidovudine alone and indinavir plus zidovudine in antiretroviral therapy-naive HIV-infected individuals with CD4 cell counts between 50 and 250/mm3.
Lewi DS, Suleiman JM, Uip DE, Pedro RJ, Souza RA, Suleiman GS, Accetturi C, Leite OM, Abreu WB, Kalichman AO, Moraes-Filho JP, Motti EF, Pecoraro ML, Makurath MR, Nessly ML, Leavitt RY. Lewi DS, et al. Among authors: kalichman ao. Rev Inst Med Trop Sao Paulo. 2000 Jan-Feb;42(1):27-36. doi: 10.1590/s0036-46652000000100005. Rev Inst Med Trop Sao Paulo. 2000. PMID: 10742724 Free article. Clinical Trial.
Improving the continuum of care monitoring in Brazilian HIV healthcare services: An implementation science approach.
Loch AP, Rocha SQ, Fonsi M, de Magalhães Caraciolo JM, Kalichman AO, de Alencar Souza R, Gianna MC, Gonçalves A, Short D, Pimenta SL, Bagnola L, Wonhnrath Menuzzo C, da Rocha Meireles Z, Natividade Diz E, Zajdenverg R, Prudente I, Battistella Nemes MI. Loch AP, et al. Among authors: kalichman ao. PLoS One. 2021 May 10;16(5):e0250060. doi: 10.1371/journal.pone.0250060. eCollection 2021. PLoS One. 2021. PMID: 33970914 Free PMC article.
16 results